Aisling Capital IV LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:26 pm Purchase | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,913,005 4.920% | 34,709 (+1.21%) | Filing |
| 2024-02-06 4:15 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,878,296 6.800% | 1,735 (+0.06%) | Filing |
| 2023-02-08 5:00 pm Purchase | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,876,561 12.340% | 10,413 (+0.36%) | Filing |
| 2022-02-14 12:16 pm Purchase | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,866,148 12.330% | 2,866,148 (New Position) | Filing |